SemBioSys Genetics Incorporated

SemBioSys Genetics is pushing the frontiers of what's possible in biotechnology by fundamentally changing the way proteins are made.

SemBioSys is using its proprietary Stratosome™ Biologics System to overcome the capital requirements, formulation, capacity and cost of goods issues facing pharmaceutical developers to help ensure that biologics addressing critical unmet needs are successfully brought to market.

Contact Details: 110, 2985 - 23rd Avenue N.E., Calgary Alberta T1Y 7L3 Canada Tel: (403) 250-5424 Fax: (403) 250-3886 Email: bauma@sembiosys.ca WWW: www.sembiosys.ca/

Loading...

Recent Publications by SemBioSys Genetics Incorporated:
Transgenic expression and recovery of biologically active recombinant human insulin from Arabidopsis thaliana seeds. The increased incidence of diabetes, coupled with the introduction of...	27th January, 2007	SemBioSys Genetics Inc, 110, 2985-23 Ave NE, Calgary, AB, T1Y 7L3, Canada.	Plant Biotechnol J. 2006 Jan;4(1):77-85. DOI Direct Link
Precise and efficient cleavage of recombinant fusion proteins using mammalian aspartic proteases. Expression of recombinant proteins as translational fusions is commonly...	3rd July, 2004	SemBioSys Genetics Inc., 110 2985 23rd Avenue NE, Calgary AB T1Y 7L3,	Protein Eng. 2003 Oct;16(10):777-83.

BioNews Results for SemBioSys Genetics Incorporated:
SemBioSys securityholder vote to be held December 18, 2009 with a record date of November 16, 2009	PR Newswire:  Nov 23 2009 12:42AM Matching: sembiosys genetics
Advitech consolidates its common shares as part of the merger of its operations with Botaneco	Yahoo! Canada:  Nov 21 2009 4:40AM Matching: sembiosys genetics
Advitech consolidates its common shares as part of the merger of its operations with Botaneco	TickerTech.com:  Nov 21 2009 8:43PM Matching: sembiosys genetics
SemBioSys Genetics to hold special meeting Dec. 18	Stockwatch:  Nov 17 2009 11:50PM Matching: sembiosys genetics
SemBioSys announces third quarter 2009 financial and operational results	KOTA Territory News:  Nov 14 2009 11:05PM Matching: sembiosys genetics
Promote your company here: BioNewsCast - Press Release Distribution	→View more SemBioSys Genetics Incorporated news.

SemBioSys Genetics Incorporated Patents:
US Patent No.	Title
7585645	Thioredoxin and thioredoxin reductase containing oil body based products
6582710	Products for topical applications comprising oil bodies
6509453	Oil bodies and associated proteins as affinity matrices
6372234	Products for topical applications comprising oil bodies
6288304	Expression of somatotropin in plant seeds
→View more SemBioSys Genetics Incorporated patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 284 times since April 2007, the link to the organisation's website has been followed 44 times

Search for more companies in Calgary

Search for more companies in Alberta

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for SemBioSys Genetics Incorporated